SpringWorks Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
SpringWorks Therapeutics, Inc.‘s stocks are currently a part of 137 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 58.99M shares of SpringWorks Therapeutics, Inc.. Compared to the previous quarter, the number grew by 7.72% or 4.22M shares more. As for the holding position changes, 38.69% (53) of current hedge fund investors increased the number of shares held, 28.47% (39) of current holders sold a part of the shares held, and 11.68% (16) closed the holdings completely. 25 hedge funds are new holders of SpringWorks Therapeutics, Inc. stock in Q3 2022, it is 18.25% of total holders.
Hedge funds holding SpringWorks Therapeutics (Q1 2019 – Q3 2022)
| Q1 2019 | 1 |
|---|---|
| Q2 2019 | 1 |
| Q3 2019 | 44 |
| Q4 2019 | 57 |
| Q1 2020 | 69 |
| Q2 2020 | 78 |
| Q3 2020 | 92 |
| Q4 2020 | 122 |
| Q1 2021 | 135 |
| Q2 2021 | 134 |
| Q3 2021 | 140 |
| Q4 2021 | 142 |
| Q1 2022 | 133 |
| Q2 2022 | 137 |
| Q3 2022 | 137 |
Hedge funds changes in SpringWorks Therapeutics positions (Q1 2019 – Q3 2022)
| Q1 2019 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2019 | 0 | 0 | 0 | 0 | 1 |
| Q3 2019 | 43 | 0 | 0 | 0 | 1 |
| Q4 2019 | 26 | 14 | 10 | 13 | -6 |
| Q1 2020 | 16 | 23 | 18 | 4 | 8 |
| Q2 2020 | 17 | 41 | 12 | 7 | 1 |
| Q3 2020 | 18 | 29 | 30 | 4 | 11 |
| Q4 2020 | 37 | 56 | 16 | 7 | 6 |
| Q1 2021 | 25 | 51 | 46 | 12 | 1 |
| Q2 2021 | 20 | 60 | 36 | 21 | -3 |
| Q3 2021 | 19 | 59 | 37 | 11 | 14 |
| Q4 2021 | 17 | 62 | 43 | 15 | 5 |
| Q1 2022 | 15 | 51 | 44 | 23 | 0 |
| Q2 2022 | 30 | 62 | 33 | 25 | -13 |
| Q3 2022 | 25 | 53 | 39 | 16 | 4 |
Hedge funds changes in SpringWorks Therapeutics stock options (Q1 2019 – Q3 2022)
| Q1 2019 | 0 | 0 |
|---|---|---|
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 231,000 |
| Q3 2021 | 317,000 | 243,000 |
| Q4 2021 | 0 | 2,699,000 |
| Q1 2022 | 33,571,000 | 29,911,000 |
| Q2 2022 | 1,317,000 | 1,869,000 |
| Q3 2022 | 17,727,000 | 1,495,000 |